ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

NCT03759340 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

56

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Alopecia Areata
Alopecia Universalis
Alopecia Totalis

Interventions

DRUG: ATI 502 0.46% Topical Solution

Sponsor

Aclaris Therapeutics, Inc.